Genetic Alliance names Miguel del Campo global advisor to RISE

Genetic Alliance has appointed pediatrician and clinical geneticist Miguel del Campo as Global Clinical and Scientific Advisor to RISE, its rare disease genomics program. The move is aimed at strengthening clinical implementation, training, and return-of-results support across RISE’s international network.

Why it matters: - Miguel del Campo’s appointment is designed to help RISE turn genomic testing into care that families can actually use. - The role adds senior clinical and scientific expertise to a global program focused on children with suspected rare genetic conditions. - The appointment also signals an emphasis on local capacity, not just access to testing.

What happened: - Genetic Alliance named Miguel del Campo, MD, PhD, Global Clinical and Scientific Advisor to RISE, the organization’s global rare disease genomics program. - Del Campo is a pediatrician and clinical geneticist and heads the Clinical and Molecular Genetics Service at Vall d’Hebron University Hospital in Barcelona, Spain. - He previously spent 10 years at the University of California, San Diego and Rady Children’s Hospital–San Diego. - His earlier roles included Professor of Pediatrics and Genetics, Chief of Clinical Genetics, and director of the Clinical Genetics training program.

The details: - Del Campo has worked with RISE since the program began. - His involvement started at the first clinical site, Hospital Infantil de las Californias in Tijuana, Mexico. - His work across the program has included patient evaluation, enrollment, informed consent, biospecimen collection, phenotypic documentation, genomic case review, return of results, and follow-up with families and referring clinicians. - In the new role, del Campo will work with clinical sites and laboratory partners across the network. - He will provide scientific and clinical guidance. - He will support multidisciplinary case and consortium discussions. - He will help identify education, training, and implementation needs. - Genetic Alliance said the goal is to give participating sites the knowledge, resources, and support needed to translate genomic findings into high-quality care. - RISE offers no-cost clinical genomic testing for children with suspected rare genetic conditions. - The program is aimed at children who face geographic, financial, or health-system barriers to testing. - RISE connects children and families with genomic testing and diagnosis through an international network of clinical sites, diagnostic laboratories, scientists, technology partners, and rare disease organizations. - The program also helps local teams interpret and return results, coordinate follow-up care, and connect families with additional resources.

Between the lines: - Genetic Alliance is prioritizing implementation support over testing alone. - The appointment suggests RISE is trying to make genomic medicine work across different health systems, not only in well-resourced settings. - Del Campo’s background in both U.S. and international clinical genetics gives him experience that fits that model. - Genetic Alliance leaders said his experience in translation, implementation, and capacity-building will help strengthen the network.

What’s next: - Del Campo will begin working closely with RISE sites and laboratory partners on clinical implementation. - The program will continue building education, training, and consortium support for participating teams. - RISE is expected to keep expanding its global clinical network as it links testing with diagnosis, follow-up, and care coordination.

The bottom line: - Genetic Alliance is using the new advisor role to push RISE beyond access to genomic testing and toward more consistent clinical care worldwide.